A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/139
A61K 39/395 (2006.01) C07K 16/30 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1341281
Gastrointestinal tumors are treated by administering to a patient afflicted with a gastroin- testinal tumor, a murine monoclonal antibody which specifically binds to an epitope of 17-1A antigen, the antibody being administered parenterally in multiple doses of 100 milligrams or more per dose for a total dose of about .1 - 5 grams of antibody. The high dose murine antibody therapy is well tole- rated in patients. Further, the anti-murine anti- body response which generally develops in treated humans, surprisingly does not alter significantly the plasma half life of the murine antibody on repeat administration. Thus, high blood levels of antibody can be achieved with sequential injections of high doses to enhance transit of the antibody from intra- vascular space into the tumor bed and thus provide higher concentrations of the therapeutic antibody to the locus of action.
541500
Carrano Richard A.
Schoemaker Hubert J.p.
Centocor Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Immunotherapy of tumor with monoclonal antibody against the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunotherapy of tumor with monoclonal antibody against the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapy of tumor with monoclonal antibody against the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1310695